Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine (Q33780088)

29 July 2017

1 reference

title

Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine (English)

1 reference

29 July 2017

1 reference

Jochmus I

1

1 reference

29 July 2017

Schäfer K

2

1 reference

29 July 2017

Faath S

3

1 reference

29 July 2017

Müller M

4

1 reference

29 July 2017

Gissmann L

5

1 reference

29 July 2017

publication date

1 July 1999

1 reference

Archives of Medical Research

29 July 2017

published in

1 reference

29 July 2017

volume

30

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

269-274

1 reference

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Transgenic plants as vaccine production systems

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Vaccination against papillomavirus in cattle.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papilloma virus 16 in H-2d mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Cell biology of antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Chimeric papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection

1 reference

https://api.crossref.org/works/10.1016%2FS0188-0128%2899%2900026-3

7 January 2021

10.1016/S0188-0128(99)00026-3

Identifiers

DOI

1 reference

29 July 2017

1 reference